Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Lucid, Nuro, and 20,000 electric vehicles

Seeking Alpha on MSN · 1d
Robotaxi revolution: Tesla and the Uber-Lucid-Nuro coalition prepare to go mainstream
The robotaxi revolution appears to be heating up. Elon Musk stated during Tesla's (NASDAQ:TSLA) earnings conference call that the company aims to roll out its robotaxi service to reach "half the population of the U.
Soy Nómada on MSN · 4d
Uber's $300 million robotaxi play: Lucid, Nuro, and 20,000 electric vehicles
Uber is investing $300 million in Lucid and taking a stake in Nuro to launch 20,000 robotaxis, signaling its return to autonomous driving.
TechCrunch · 8d
Uber makes multimillion-dollar investment in Lucid and Nuro to build a premium robotaxi service
Uber is investing hundreds of millions of dollars into Lucid and autonomous vehicle technology startup Nuro in a bid to launch its own robotaxi service.
7d
Lucid stock pops 43% after Uber announces robotaxi. What to know about the Tesla rival
Lucid's share price is on the move. Here's what its partnership with Uber and Nuro means for the future of transportation.
2d
Tesla Rival Lucid's CEO Hails Chinese EVs, Reiterates Commitment To US Robotaxi Operations With Uber
Lucid Group's interim CEO Marc Winterhoff praised Chinese EVs and Robotaxis, highlighting their quality and fit and finish ...
5d
Uber: Many Uncertainties Significantly Cloud Robotaxi Move
Uber invests in Lucid and Nuro to counter Tesla and Waymo's robotaxi dominance. Check out UBER's strategic shift, $7B ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy